BioNTech leads us into a new age of medical agriculture—plant 'em this year, pick 'em next
At last, life-saving medicines grow on trees...
Intriguing article from GB News
Yesterday, I noticed an intriguing article published in GB News.
Cancer vaccine could become available in 2023, according to scientists behind Covid-19 jab
In it, Prof Tureci of BioNTech said: “We have learned how to better, faster manufacture vaccines.”
The day before…
Only the day before, I’d posted this article:
BioNTech—the virtual company with a virtual moral compass
This excerpt summaries the rise (not fall, yet) of BioNTech:
“In 2014, with nothing more than safety studies (Phase 1) started in melanoma (this is the cancer they talk about), BioNTech struck numerous deals through 2014 - 2018:
“Strategic collaborations across the pipeline (Bayer Animal Health, Genentech, a member of the Roche Group, Genmab, Siemens, Sanofi, Regeneron, Genevant, Pfizer, University of Pennsylvania)”
Excuse me, why would all these companies do business with BioNTech—they had nothing of proven value, diddly squat, in the pipeline. In normal times, going to these companies with j…